Log In
Print
BCIQ
Print
Print this Print this
 

COVA322

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionDual bispecific inhibitor of tumor necrosis factor (TNF) and IL-17A
Molecular Target Tumor necrosis factor (TNF) ; Interleukin-17A (IL-17A)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today